Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01769014
Recruitment Status : Unknown
Verified January 2013 by Psychiatrische Dienste Graubuenden.
Recruitment status was:  Enrolling by invitation
First Posted : January 16, 2013
Last Update Posted : January 16, 2013
Information provided by (Responsible Party):
Psychiatrische Dienste Graubuenden

Brief Summary:
It is the goal of this study adherence and quality of life in a population of people suffering from schizophrenia or schizoaffective disorder and to analyze if these factors are influenced by treatment, support, social services, and residential treatment. The study population is drawn from the the cantons Glarus and Graubunden as well as Liechtenstein.

Condition or disease
Schizophrenia Schizoaffective Disorder Quality of Life

Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: In the Cantons Graubunden and Glarus as Well as in the Principality of Liechtenstein: Influence of Intensive Outpatient Treatment of People With Schizophrenia and Schizoaffective Disorder on Quality of Life and Adherence
Study Start Date : January 2013
Estimated Primary Completion Date : April 2013
Estimated Study Completion Date : December 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia
U.S. FDA Resources

Primary Outcome Measures :
  1. Quality of life [ Time Frame: 3 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
People who suffer from schizophrenia or schizoaffective disorder, following DSM IV criteria and who live in the cantons Glarus, Graubuenden or the Principality of Liechtenstein.

Inclusion Criteria:

  • Schizophrenia or schizoaffective disorder
  • 18 - 65 years old
  • treated in the PDGR within the past 19 years

Exclusion Criteria:

  • organic brain disorder
  • alcohol or drug dependence
  • low intelligence
  • unable to give consent
  • no legal competency
  • lacking knowledge of German language
  • current psychiatric inpatient treatment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01769014

Psychiatrische Dienste Graubuenden
St. Moritz, Graubuenden, Switzerland, 7500
Sponsors and Collaborators
Psychiatrische Dienste Graubuenden

Responsible Party: Psychiatrische Dienste Graubuenden Identifier: NCT01769014     History of Changes
Other Study ID Numbers: KEK-ZH-Nr.2012-0178
First Posted: January 16, 2013    Key Record Dates
Last Update Posted: January 16, 2013
Last Verified: January 2013

Keywords provided by Psychiatrische Dienste Graubuenden:

Additional relevant MeSH terms:
Psychotic Disorders
Pathologic Processes
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders